Reumo Flex caplets — Class I drug recall D-0225-2024
Ongoing recall by Botanical Be, reported 2023-12-06, distributed nationwide. Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.
| Recall number | D-0225-2024 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Botanical Be, El Paso, TX, United States |
| Recall initiated | 2023-10-20 |
| Classified | 2024-01-12 |
| Reported by FDA | 2023-12-06 |
| Distributed | Nationwide (US) |
| Reason classes | undeclared allergen, unapproved product |
| Expiration dates | 2024-10-20 |
Product
Reumo Flex caplets, packaged in 30-count boxes, Manufactured by: Grupo Yepenza de Mexico, SA de CV, Comerciantes 5824 Col Arcos de Guadalupe, Zapopan Jal Mexico, UPC 7 502214 014598
Reason for recall
Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0225-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.